Harrow Health is trading 5% up now at $38.84 after investors reacted to BlackRock’s disclosed 2,740,117-share position.
- The position is valued at approximately $116.37 million, representing 7.35% ownership; the disclosure signals stronger institutional sponsorship and likely supported demand on September 2, 2026.
- Harrow announced participation in three September investor conferences, including Cantor and H.C. Wainwright events. Broader healthcare strength provides additional support, but the BlackRock stake is the clearest company-specific catalyst.